NCCN collaborates with Reno Medical to publish regional adaptations of the NCCN Guidelines® for use in Asia. Adaptations of the NCCN Guidelines are developed by the host country’s oncology thought leaders in conjunction with NCCN Guidelines Panel members. Modified NCCN Guidelines are developed to aid clinicians in determining appropriate and efficient avenues of care in the specified country. Participants include NCCN Guidelines Panel members and a panel of multidisciplinary specialists from China, Japan, South Korea, and Taiwan, who engage in consensus discussions. These adaptations, the Asia Consensus Statements, are English-language manuscripts designed to provide clinical resources for Asian specialists who are involved in the management of cancer patients within the represented countries.
NCCN has consented to direct non-adapted translations of the Complete Library of NCCN Guidelines into Japanese by a major, national university in Kyoto, Japan. These translations are part of a large endeavor by Foundation for Biomedical Research and Innovation at Kobe to translate the Complete Library of NCCN Guidelines into non-adapted Japanese translations. Each translation of the NCCN Guidelines is managed by the appropriate medical society in Japan to ensure its accuracy for use by Japanese clinicians in the treatment of their patients.